• SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline B3Cnewswire
    December 03, 2021
    SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced today that is has secured €280m of funding to significantly expand and advance its clinical pipeline, including its lead asset SOT101...
  • NBE-Therapeutics Closes USD 22M Series C Financing Round b3cnewswire
    January 17, 2020
PharmaSources Customer Service